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ABSTRACT 
Objective: In the present study an attempt has been made by the use of a computational approach to investigate putative drug targets in 
Staphylococcus aureus. 
Methods: In silico comparative analysis of the metabolic pathways between the pathogen and the Bos taurus was carried out. Further detection of 
bacterial genes that are non homologous to host, but are essential for the survival of the pathogen represents a promising means of identifying novel 
drug targets. Metabolic pathways were obtained from the metabolic pathway database Kyoto Encyclopedia of Genes and Genomes (KEGG) and were 
compared to identify unique pathways present only in the pathogen and absent in the host. 
Results: We have identified total 1930 proteins, which are non homologous to Bos taurus protein sequences and among them 374 enzymes are 
found to be essential for survival of the S. aureus according to the database of essential genes (DEG) database. Further, 10 proteins were predicted 
as cytoplasmic and cell wall associated proteins, which could serve as potential drug target candidates. 
Conclusion: The identified potential drug targets form a platform for further investigation in discovery of novel therapeutic agents against S. aureus. 
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INTRODUCTION 
Mastitis is an inflammatory disease of the mammary gland and is 
one of the most costly diseases of dairy animals which result in 
severe economic losses from reduced milk production, treatment 
cost, increased labor, withheld milk following treatment and 
premature culling of animals. The most common mastitis pathogens 
are found either in the udder as contagious pathogens or in the 
animal surroundings environmental pathogens such as in bedding 
and manure soil. Among the contagious pathogens, the most 
common is S. aureus [1]. It is considered as the main etiological 
agents responsible for mastitis and also responsible for significant 
economic losses all over the world [2]. In recent years, the incidence 
of antimicrobial-resistant in these bacteria has increased and is 
considered one of the reasons for low cure rates [3]. 
The process of drug design, development and commercialization is a 
tedious, cost-intensive and time-consuming process [4]. To 
overcome these challenges, several multidisciplinary approaches are 
required for the process of drug development. In silico drug 
designing is a form of computer-based modeling which is useful in 
drug discovery processes. 
Identification of novel drug targets is required to develop new 
classes of drugs in order to overcome drug resistance and replace 
less efficacious treatments. The search for novel drug targets relies 
on the genomics data. The comparative and subtractive genomics 
approach can be used for selecting non homologous genes coding for 
proteins, which are present in pathogens but not in the host. This 
type of approach has been previously used in earlier studies for 
finding putative drug targets [5-7]. So the aim of the present study 
was to determine putative drug targets of S. aureus using in silico 
approach. 
MATERIALS AND METHODS 
To identify the essential genes of Staphylococcus aureus, the 
complete proteome sequence of S. aureus was retrieved from NCBI. 
The proteins sequences were subjected to CD-HIT [8] analysis with a 
sequence identity cutoff of 0.8, to eliminate redundant sequences 
with more than 80% identity. The resultant proteins sequences 
were further used for the study. These sequences were further 
BLAST with the host genome i. e Bos Taurus. Proteins with an E-
value (expectation value), 10^4 were eliminated, assuming that they 
have a certain level of homology with the host genome [9]. The 
resultant sequences had no homology with the host proteome. The 
next step was to identify the genes involved in the metabolic 
pathways in S. aureus. For this, the resultant non homologous 
protein to host was subjected to BLASTP analysis with a database of 
essential genes (DEG) which contain all the essential genes [10]. The 
sequencing thus obtained that could be considered as drug targets 
because they are not present in the host. 
Further analysis was conducted on these essential proteins to 
determine their subcellular localization and function. The KAAS 
(KEGG Automatic Annotation Server) 
RESULTS AND DISCUSSION 
of the Kyoto Encyclopedia of 
Genes and Genomes (KEGG) was used to identify the functions [11]. 
The server provides functional annotation of genes by BLAST (Basic 
Local Alignment Search Tool) comparisons against the manually 
curated KEGG database. The program PSORTb V.3.0 [12] was used 
for subcellular localization prediction. Drug ability of the predicted 
10 drug targets were further checked using Drug Bank. The drug 
Bank Database is a distinctive bioinformatics and chem informatics 
resource that combines detailed drug data with comprehensive drug 
target information. 
Development of novel drugs with potential therapeutic applications 
is one of the most complex and complicated process. It is quite 
obvious that increase of drug resistance properties requires more 
potential targets and by this in silco approaches increases the 
probability of success and also reduces the effort of the wet lab. In 
this present study we have tried to evaluate the targets could be a 
better target for rational drug designing. 
The proteome of S aureus had a total of 2607 proteins. BLAST 
analysis of these proteins against the Bos taurus genome revealed 
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677 proteins that were homologous with the host genome and 1930 
proteins are nonhomologous (table 1). Non homologous proteins as 
drug targets might lead to unwanted cross-reactions and 
cytotoxicity. However, this approach was also done to find potential 
drug targets in Bovine Herpes Virus 4 causing bovine mastitis [13]. 
Subtractive genomics approach is a powerful-method to identify the 
specific genes, which are present in the pathogen but absent in the 
host. Thus helps in the identification specific genes of an organism, 
which can be used as drug targets [14]. Comparative and subtractive 
genomics have been widely used for the prediction and 
identification of potential therapeutic targets and vaccine candidate 
proteins in numerous pathogenic bacteria and also fungi [5, 15, 16]. 
Hence, non homologous proteins were selected for further 
identification of essential genes using DEG database.  
The functions encoded by essential genes are considered to 
constitute the foundation of life in the organism. It has been 
reported that essential gene products of microbial cells are 
promising new targets for antibacterial drugs [10]. Essential genes 
unique to an organism can be considered as species-specific drug 
targets [17]. DEG has been widely utilized by other researchers for 
identified of putative drug targets [18, 19]. 374 essential genes are 
found when BLAST against the DEG database (table 1).  
This is in agreement with the experimentally determined essential 
genes 658 number [20] and through transposon-mediated 
differential hybridization identification of essential genes of 351 
numbers in the S. aureus [21]. 
Table 1: Results of subtractive proteomic and metabolic 
pathway analysis for S. aureus 
Total no. of proteins 2607 
Nonparalogous (non homologous to host) 1930 
Essential proteins in DEG 374 
Essential proteins involved in metabolic pathways 278 
Cell wall associated proteins 4 
Cytoplasmic membrane associated proteins 6 
 
Out of 374 essential proteins, 278 proteins were found to be involved in 
metabolic pathways. Computational prediction of bacterial protein 
localization provides a quick and inexpensive means for gaining insight 
in to protein function [22].  
The protein localization study revealed that among the 278 proteins 
essentially involved in metabolic pathways, 6 proteins were present in 
cytoplasm and 4 is cell wall associated (table 2). Out of 10, two common 
potential drug targets were found to be highly similar to the target 
proteins in drug bank (table 3).  
The computational genomics approach [23, 24] stated here, will speed 
up the drug discovery process by removing hindrances like dead-ends 
or toxicity that are encountered in classical approaches. We anticipate 
that future research based on this study will eventually provide 
interesting targets that can be successfully moved to drug 
development.
 
Table 2: Putative drug targets of S. aureus 
Query 
ID 
Protein function Localization DEG accession number Gene reference Length 
(AA) 




DEG10170336 GI: 88196215 267 




DEG10020122 GI: 15926817 1188 
Q2FJH7 N-acetylmuramoyl-L-alanine 
amidase sle1  
Cell wall 
associated 
DEG10170336 GI: 88196215 267 
Q2FIX4 CHAP domain family  Cell wall 
associated 
DEG10170336 GI: 88196215 267 
Q2FG20 Septation ring formation 






























DEG10020258,DEG10170314 GI: 15927810,GI: 
88196142 
430 





DEG10170178 GI: 88195086 384 
Q2FI21 Fmt protein Cytoplasmic 
membrane 
associated 
DEG10170108 GI: 88194754 397 
 
Table 3: Drug ability of the predicted drug targets 
Query 
ID 
Drug bank target Drug bank Accession no. Putative drugs 
Q2FFM1 Penicillin-binding 
protein 1A 
DB01414, DB01327, DB00274, DB01328, 
DB01329, DB01331, DB00430, DB01333, 
DB00438, DB,01415, DB01332, DB00303, 
DB01598, DB04570 
Cefacetrile, Cefazolin, Cefmetazole, Cefonicid, 
Cefoperazone, Cefoxitin, Cefpiramide, Cefradine, 




DB03820, DB02514, DB04488, DB04340, 
DB00456, DB02136, DB03313, DB03450, 
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In silico approach has been of great importance to develop fast and 
accurate target identification and prediction method for the 
discovery. Targets found are inevitable for the growth of the 
organisms. The current study can be carried forward to design a 
drug that can block these targeted proteins. Microorganisms are fast 
gaining resistance to the existing drugs. Thus designing better and 
effective drugs need a faster method. 
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